Innate signalling (TLR / RLR) frames
In THP-1 monocytes and donor blood cells, papers describe thymogen activating TLR and RLR signaling pathways, discussed alongside ingavirin in the same experimental frame.
identity
sequence
Glu · Trp
Key takeaways
- Thymogen is the defined dipeptide Glu-Trp carved from the older thymus extract Thymalin in the Khavinson / Morozov bioregulator line.
- Mapped themes include TLR/RLR signalling frames, trauma-combination neutrophil work, aged-spleen apoptosis markers, and hematologic / innate-immunity series.
- Full-text density is high in Khavinson-adjacent Russian labs (Sokolova, Cherdakov, Kasimova and related groups). that St. Petersburg thymic-peptide shelf is where the corpus lives.
What it is
Thymogen sits in the Khavinson / Morozov bioregulator line at the St. Petersburg Institute of Bioregulation and Gerontology. the synthetic dipeptide Glu-Trp carved from the older thymus extract Thymalin.
Thymogen is a defined dipeptide. Thymalin is a calf-thymus polypeptide fraction. Different products on the same shelf.
We feature it because it is one of the most mapped thymic-series compounds in our archive, with both PubMed abstracts and a large CyberLeninka full-text set.
What the literature describes
Themed chapters drawn only from papers already mapped on this dossier. Archive map. No medical advice.
Trauma combinations and neutrophil readouts
Combination trauma papers (rat femoral fracture and skin trauma) report thymogen giving strong neutrophil stimulation when paired with dalargin and glycyl-histidyl-lysine.
Aged spleen and apoptosis markers
Aged-rat spleen culture work reports thymogen affecting apoptosis-marker expression (one finding; aging and “mechanism” glosses in the old map were near-duplicates).
Hematologic and innate-immunity series
Hematologic animal reports describe rises in leukocytes, erythrocytes, and hemoglobin after thymogen in mouse and cattle models.
Later Russian papers discuss modulation of innate-immunity factors in respiratory-infection and COVID-19 prevention settings. still archive descriptions, not clinical advice.
Research trail
A large share of the mapped full texts come from Khavinson-adjacent Russian labs (Sokolova, Cherdakov, Kasimova and related groups). the St. Petersburg thymic-peptide shelf is where this corpus lives.
PubMed adds older clinical and experimental titles across immunology and surgery journals that sit in the same Russian / CIS literature ecology.
Open limits
- How should combination papers with unrelated peptides (dalargin, glycyl-histidyl-lysine) be read for single-agent claims?
- Is TLR/RLR activation direct receptor binding or mediated by intermediate cells?
- What archive gaps remain between experimental series and later clinical-adjacent titles in the mapped set?
Russian full-text papers
- vliyanie alfa glutamil triptofana na fonovuyu i indutsirovannuyu aktivnost faktorov vro Russian full text
- primenenie regulyatornyh peptidov timogena dalargina glitsil gistidil lizina i ih kombi Russian full text
- signalnye tlr rlr mehanizmy immunomoduliruyuschego deystviya preparatov ingavirin i tim Russian full text
- sinergichnoe immunotropnoe i reparativnoe deystvie timogena dalargina i regulyatornogo Russian full text
- nespetsificheskaya rezistentnost u novorozhdennyh telyat pod vliyaniem timogena Russian full text
- dinamika lokalnyh izmeneniy i skorosti zazhivleniya posleoperatsionnyh ran pri ispolzov Russian full text
- immunotropnye antioksidantnye i reparativnye effekty novogo analoga timogena modifitsir Russian full text
- sinergichnoe antioksidantnoe i reparativnoe deystvie timogena dalargina i peptida gly h Russian full text
8 curated · off-topic veterinary-price / superovulation rows removed
Also on PubMed
- 2020 [Age features of bioregulatory therapy of dental diseases.]. PubMed
- 2013 [Peptide bioregulators: the new class of geroprotectors. Message 2. Clinical studies results]. PubMed
- 2006 [Decision on the immunomodulating therapy in unspecific osteomyelitis of the spine]. PubMed
- 1999 [Effect of thymus polypeptide fractions on the development of rat thymus and spleen in organ culture]. PubMed
- 1999 Modern Immunotherapy in Clinical Medicine: Present and Future. PubMed
- 1998 [Immunotherapy of pulmonary tuberculosis]. PubMed
- 1996 [Use of immunomocorrection in the combined treatment of laryngeal papillomatosis in children]. PubMed
- 1993 [The protective effect of peptides from the thymus and tracheal mucosa in an experimental respiratory influenzal infection]. PubMed
- 1992 [The effect of the synthetic immunomodulator thymogen on radiation-induced carcinogenesis in rats]. PubMed
- 1991 [Effect of thymagen, thymalin and vilosen on the cAMP and cGMP levels and phosphodiesterase activity in spleen lymphocytes during sensitization and anaphylactic shock]. PubMed
10 curated
Still open
- Is thymogen better read as a thymus substitute or as a general innate-immunity signaling booster?
- Why do combination papers pair it with unrelated peptides (dalargin, glycyl-histidyl-lysine)?
- Is TLR/RLR activation direct receptor binding or mediated by intermediate cells?
- What exists for clinical translation outside the Russian Federation in sources we mapped?
Reviewed against the archive corpora on 2026-09-19. Source-grounded. No clinical claims. Archive / history / research only. No medical advice. No dosing, synthesis, sourcing, or health claims.